This inventor holds 3 USPTO granted patents. Top assignees: Merck + Co., Inc., University of Virginia Patent Foundation. Active years: 1993-1995.
Company Filing History:
3 out of 4,770 
1 out of 1,040 
Years Active: 1993-1995
Title: The Innovations of Robert W. Stieber
Introduction
Robert W. Stieber is a notable inventor based in Harrisonburg, VA (US). He has made significant contributions to the field of biochemistry, particularly in the development of HMG-CoA reductase inhibitors. With a total of 3 patents, his work has had a considerable impact on the pharmaceutical industry.
Latest Patents
Stieber's latest patents include a process for the synthesis of acylated HMG-CoA reductase inhibitors. This innovative process employs an immobilized lipase in an organic solvent to esterify diol lactone derivatives of HMG-CoA reductase inhibitors, allowing for the efficient, one-step production of these inhibitors. Another significant patent involves the discovery of novel strains of Aspergillus terreus, which provide fermentation production of at least 5.2 g/L of triol acid, a compound that serves as an inhibitor of HMG-CoA reductase and is useful as an antihypercholesterolemic agent.
Career Highlights
Throughout his career, Stieber has worked with prominent organizations such as Merck & Co., Inc. and the University of Virginia Patent Foundation. His expertise in biochemistry and patent development has positioned him as a key figure in the advancement of pharmaceutical innovations.
Collaborations
Stieber has collaborated with notable individuals in his field, including William H. Cover and Rebecca L. Dabora. These partnerships have contributed to the successful development of his patented technologies.
Conclusion
Robert W. Stieber's contributions to the field of biochemistry and his innovative patents have made a lasting impact on the pharmaceutical industry. His work continues to influence the development of important medical treatments.